News

/News
612, 2017

Atomo HIV Self Test approved by Expert Review Panel

Atomo Diagnostics' CEO, John Kelly, today announced that the Atomo HIV Self Test has been approved by the World Health Organisation’s Expert Review Panel for Diagnostics (ERP-D); a special process determined by Unitaid and The Global [...]

1010, 2017

CE Marking granted for Atomo HIV Self Test

Atomo Diagnostics' CEO John Kelly announced today that the Atomo HIV Self Test has been granted CE Marking by a European Union Notified Body. The company is now actively engaging with commercialisation and distribution partners to make the test [...]

2504, 2017

CEO John Kelly welcomes Doris-Ann Williams MBE to the Board of Atomo

Atomo Diagnostics has today announced that Doris-Ann Williams MBE, has been appointed to join its Board of Directors. Doris-Ann is Chief Executive of the British In Vitro Diagnostics Association (BIVDA) and has worked in the [...]

2002, 2017

Canadian Government Fund Invests in Atomo

Delighted to welcome new investors for 2017, earlier this month Atomo Diagnostics announced backing from Grand Challenges Canada (GCC). Investment from the Canadian Government-funded agency totalling US$1 million (A$1.31 million, C$1.32 million), in recognition of [...]